共 50 条
- [31] Initiating or Switching to Insulin Degludec/Insulin Aspart in Adults With Type 2 Diabetes in the Philippines: Results from a Prospective, Non-interventional, Real-World Study [J]. JOURNAL OF THE ASEAN FEDERATION OF ENDOCRINE SOCIETIES, 2024,
- [32] Initiating or Switching to Insulin Degludec/Insulin Aspart in Adults with Type 2 Diabetes in Malaysia: Results from a Prospective, Non-interventional Real-World Study [J]. JOURNAL OF THE ASEAN FEDERATION OF ENDOCRINE SOCIETIES, 2023, 38 (01): : 37 - 44
- [33] Therapeutically interchangeable? A study of real-world outcomes associated with switching basal insulin analogues among US patients with type 2 diabetes mellitus using electronic medical records data [J]. DIABETES OBESITY & METABOLISM, 2015, 17 (03): : 245 - 253
- [37] Initiating or Switching to Insulin Degludec/Insulin Aspart in Adults with Type 2 Diabetes: A Real-World, Prospective, Non-interventional Study Across Six Countries [J]. Advances in Therapy, 2022, 39 : 3735 - 3748
- [38] iGlarLixi versus premixed insulin initiation in adults with type 2 diabetes advancing from basal insulin therapy: The SoliComplex real-world study [J]. DIABETES OBESITY & METABOLISM, 2023, 25 (05): : 1249 - 1260
- [39] Real-World Patterns of Basal Insulin Use with Other Diabetes Medications Among People with Type 2 Diabetes Between 2014 and 2020 [J]. Diabetes Therapy, 2023, 14 : 1157 - 1174